Phrontline Biopharma: Funding, Investors & Team (Nov 2026)
Phrontline Biopharma develops biopharmaceutical products to treat cancer through innovative antibody-drug conjugate technology.
Phrontline Biopharma has raised $40.0M across 1 funding round on record, the most recent a Series A of $40.0M announced in Nov 2026.
That round is above the $15M median round size for China companies tracked on FundedIQ over the last two years.
Phrontline Biopharma Company Profile and Key Stats
Latest funding round on record: Nov 2026.
Phrontline Biopharma Funding Rounds
Phrontline Biopharma Investors
14 investors are recorded in total; the 5 named above are those the record identifies.
Phrontline Biopharma Founders and Leadership Team
Contact details for the Phrontline Biopharma team: 1 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Phrontline Biopharma Funding in Context
Phrontline Biopharma's latest round of $40.0M is above the median round in China. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Phrontline Biopharma in Biopharma and Shanghai
Companies Similar to Phrontline Biopharma
Fortsense is an AI-aware chip designer, focusing on core component design, outsourcing semiconductor supply…
Lips Semiconductor is a developer and producer of power semiconductor components for new energy vehicles and…
UniX AI develops general-purpose humanoid robots for real-world applications.
Sanyou Bio provides biopharmaceutical research and development services, focusing on the discovery and…
coScene provides data infrastructure, data processing, and research support for spatial intelligence and…
Huasaiboman Medical Cell Biology is a biotechnology company engaged in providing new cell therapy…
Afana Biotechnology is a company that provides research and development for mRNA technology, sequence…
Lingchuan Technology is a high-tech enterprise focusing on transcoding/AI chip research and development.
Boyi Biotechnology provides vital raw materials and complete solutions to biomedical customers in the in…
Guoquangzi is a manufacturer of quantum precision measurement devices.
Enjosim specializes in the R&D, manufacturing, and sales of self-delivery systems, particularly those for…
Echiev is a developer of autonomous driving technology and application products includes intelligent and…
Phrontline Biopharma Funding FAQs
What does Phrontline Biopharma do?
Phrontline Biopharma develops biopharmaceutical products to treat cancer through innovative antibody-drug conjugate technology.
How much funding has Phrontline Biopharma raised?
Phrontline Biopharma has raised $40.0M across 1 round on record. The most recent is a Series A of $40.0M announced in Nov 2026.
When did Phrontline Biopharma last raise funding?
Phrontline Biopharma's most recent funding round on record is a Series A of $40.0M, announced in Nov 2026.
Who has invested in Phrontline Biopharma?
Investors on record for Phrontline Biopharma include Decheng Capital, Med-Fine Capital, Oriza Holdings, Xiamen C&D Emerging Industry Equity Investment, Sino Biopharmaceutical. FundedIQ records 14 investors in total.
Who is the CEO of Phrontline Biopharma?
Min Zhao is listed as CEO at Phrontline Biopharma.
Where is Phrontline Biopharma headquartered?
Phrontline Biopharma is based in Shanghai, China.
How many employees does Phrontline Biopharma have?
Phrontline Biopharma is in the 11-50 employee band.
When was Phrontline Biopharma founded?
Phrontline Biopharma was founded in 2022.
About FundedIQ's Phrontline Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Phrontline Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.